Navigation Links
IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008
Date:6/17/2008

ectors approved one-time bonuses paid in the first quarter of 2008 related to the Company's IPO of $0.3 million, which decreased the Company's pro-forma fully diluted earnings per share for the first quarter of 2008 by $0.01. IPC computes its adjusted pro-forma fully diluted earnings per share excluding these one-time bonuses to reflect its on-going operations. IPC's management believes that while excluding the one-time bonuses from the calculation of pro-forma fully diluted earnings per share is considered a non-GAAP measure, it more clearly depicts the operating performance of the Company and enables more appropriate period-to-period measures. However, adjusted pro-forma fully diluted earnings per share is a non-GAAP measure and thus should not be used as a substitute for pro-forma fully diluted earnings per share.

The Company's guidance for 2008 is based upon assumptions that the Company's management believes reasonable, but there can be no assurance that these future results will be achieved.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at http://www.hospitalist.com.

Safe Harbor Statement

Certain s
'/>"/>

SOURCE IPC The Hospitalist Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
2. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
3. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
4. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
5. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
6. Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner
7. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
8. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
9. The Jordan Company, L.P. Has Teamed with the Management of Haas TCM Inc. to Form Haas TCM Group Inc.
10. Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
11. Study Reaffirms Superiority of Trofile(TM) Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 Minerva Neurosciences (NASDAQ: ... therapies to treat neuropsychiatric diseases and disorders, today announced ... vice president of finance and chief accounting officer, effective ... senior executive with more than 20 years of experience ... science companies. His background includes the management of compliance ...
(Date:7/14/2014)... July 14, 2014 PatientCrossroads, ... platform, announced that three PatientCrossroads-based patient registries—DuchenneConnect, ... Phelan-McDermid Syndrome International Registry; and the NephCure ... awarded contracts by the Patient-Centered Outcomes Research ... of a new health data network called ...
(Date:7/13/2014)... University) -- The discovery 30 years ago of soccer-ball-shaped ... of nanotechnology research. Now, there appears to be a ... University, Shanxi University and Tsinghua University in China have ... a hollow molecular cage similar to a carbon buckyball. ... structurepreviously only a matter of speculationdoes indeed exist. , ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 2014 Deep ... is a professional and in-depth study on the current ... China. , The report provides a basic overview of ... Global market analysis and Chinese domestic market analysis are ... competitive landscape of the market. A comparison between the ...
Breaking Biology Technology:Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3
... but its repair could actually increase warming in the southern hemisphere, ... The Antarctic ozone ... but the discovery of a previously undiscovered feedback shows that it ... the past two decades. High-speed winds in the area ...
... , Jan. 25 Novavax, Inc. (Nasdaq: ... company will be presenting at the upcoming Phacilitate Vaccine Forum ... at the Grand Hyatt, Washington, D.C.  Mr. ... Alliances will be participating in a Focus Session: Fast ...
... AMSTERDAM, The Netherlands ... (Euronext: AMT), a leader in the field of,human ... the official,marketing authorisation process for its lead product ... The submission,of the Glybera(R) Marketing Authorisation Application (MAA), ...
Cached Biology Technology:Ozone hole healing could cause further climate warming 2NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010 2EMA Starts Formal Review of Glybera(R) Dossier 2EMA Starts Formal Review of Glybera(R) Dossier 3
(Date:7/11/2014)... German . ... the refraction of X-rays through a specimen instead of ... method are often of much higher quality than those ... Prof. Franz Pfeiffer are particularly interested in developing new ... X-ray phase-contrast imaging. One main goal is to make ...
(Date:7/11/2014)... researchers at the National Institute of Standards and ... their work more effectively, they often prove that ... was the case recently for M. Lorna De ... the growing specialization of glycomics. Glycomics is the ... glycans that are attached to proteins and lipids ...
(Date:7/11/2014)... China Researchers from Salk Institute for Biological Studies, ... evaluated the safety and reliability of the existing ... new method, TALEN-HDAdV, which could significantly increased gene-correction ... This study published online in Cell Stell ... stem cell-based gene therapy. , The combination of ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2
... IOF World Congress on Osteoporosis 2008 (IOF WCO), to ... registration to benefit from special early bird rates. The ... 3-7, 2008, is the worlds largest scientific congress devoted ... to IOF Members, Non-Members and Students or Fellows, with ...
... hereditary disorder that strongly predisposes carriers to develop cancer ... Asian female, report researchers today at the American Association ... Generally, a person should have two normal copies ... the disorder known as Li-Fraumeni syndrome (LFS), one defective ...
... announced the results of a systematic effort to map ... cause of cancer deaths. Appearing in the November 4 ... provides a comprehensive view of the abnormal genetic landscape ... regions that are frequently gained or lost in human ...
Cached Biology News:Rare cancer-causing syndrome found, for the first time, in Singapore 2Genome study charts genetic landscape of lung cancer 2Genome study charts genetic landscape of lung cancer 3
... Fujifilm Life Science LAS-3000mini is a ... to chemiluminescence applications, and the perfect ... Fuiji 's LAS-3000 provides significantly improved ... , Glowell calibration standards validate that ...
Designed for use with the Agencourt CleanSEQ and Agencourt AMPure 384-well SPRI reagent kits. For use with 384-well thermal cycling plates....
... ScriptCap™ m7G Capping system ... and all of the components ... 0 on the end of ... These kits feature high efficiency ...
... Fujifilm Life Science FLA-5100 imaging system allows ... large as 40 x 46cm at a ... This system is especially suitable for protein ... array analysis for genomics., Fuji s FLA-5100 ...
Biology Products: